MedPath

Cistra

Brand Name: Cistra

Generic Name: Cisatracurium (as besilate)

Active
Registration Number

DR-XY48089

Dosage Form

Solution for Injection (IV)

Issuance Date

June 3, 2022

Expiry Date

June 3, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2 mg/mL (10 mg/5 mL)
Packaging7 mL-capacity USP Type I clear and colorless glass vial sealed with bromobutyl rubber stopper and aluminum flip-off cap (Box of l’s)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Neuromauscular Blocker
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cisatracurium (as besilate)Active
Monograph: cisatracurium (as besilate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform